Drug-Chemo Combo Increases Breast Cancer Treatment Efficacy
July 23, 2024
July 23, 2024
ANN ARBOR, Michigan, July 23 (TNSres) -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
Preclinical models show that combining an inhibitor of a metabolic pathway with chemotherapy could improve outcomes in triple-negative breast cancer brain metastases
* * *
A study from the University of Michigan Health Rogel Cancer Center finds that giving a fatty acid inhibitor alongside chemotherapy could improve th . . .
* * *
Preclinical models show that combining an inhibitor of a metabolic pathway with chemotherapy could improve outcomes in triple-negative breast cancer brain metastases
* * *
A study from the University of Michigan Health Rogel Cancer Center finds that giving a fatty acid inhibitor alongside chemotherapy could improve th . . .